| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/09/2009 | WO2008156645A3 Pharmaceutical compositions and uses |
| 04/09/2009 | WO2008149163A3 Potassium ion channel modulators and uses thereof |
| 04/09/2009 | WO2008144754A3 Methods of treating inflammatory disorders using isoforms of receptor tyrosine kinases |
| 04/09/2009 | WO2008138943A3 Prophylactic and therapeutic use of sirtuin inhibitors in tnf-alpha mediated pathologies |
| 04/09/2009 | WO2008122667A3 Ureylene derivatives |
| 04/09/2009 | WO2008088849A9 Inflammation treatment, detection and monitoring via trem-1 |
| 04/09/2009 | WO2008073623A3 Soluble epoxide hydrolase inhibitors |
| 04/09/2009 | WO2008067909A3 Urea and sulfamide derivatives as tafia inhibitors |
| 04/09/2009 | US20090093634 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders |
| 04/09/2009 | US20090093617 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 04/09/2009 | US20090093543 Optimized strains of yarrowia lipolytica for high eicosapentaenoic acid production |
| 04/09/2009 | US20090093542 Copper antagonist compositions |
| 04/09/2009 | US20090093535 Method and composition for treating heart failure |
| 04/09/2009 | US20090093524 Compounds and methods for modulating fxr |
| 04/09/2009 | US20090093518 Piperidinyl-substituted isoquinolone derivatives |
| 04/09/2009 | US20090093516 Triazolopyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 04/09/2009 | US20090093515 Substituted pyrroline kinase inhibitors |
| 04/09/2009 | US20090093483 enzyme inhibitor for treating ischemia, anemia, wound healing, auto-transplantation, allo-transplantation, xeno-transplantation, systemic high blood pressure, thalassemia, diabetes, cancer, and inflammatory disorders; N-((4-hydroxy-2-oxo-6-(trifluoromethyl)-2',3',5',6'-tetrahydro-2H-spiro[naphthalene-1,4 |
| 04/09/2009 | US20090093478 N-aroyl cyclic amines |
| 04/09/2009 | US20090093451 IL-8 Receptor Antagonists |
| 04/09/2009 | US20090093442 Uses of water-soluble cellulose derivatives for preventing or treating metabolic syndrome |
| 04/09/2009 | US20090093433 SENSE mRNA THERAPY |
| 04/09/2009 | US20090093419 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 04/09/2009 | US20090093413 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 04/09/2009 | US20090093412 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 04/09/2009 | US20090093409 Neuroprotective synergy of erythropoietin and insulin-like growth factors |
| 04/09/2009 | US20090092684 Small molecule antagonists of bcl-2 family proteins |
| 04/09/2009 | US20090092667 Method for Reducing Amyloid Deposition, Amyloid Neurotoxicity, and Microgliosis with (-)-Nilvadipine Enantiomer |
| 04/09/2009 | US20090092618 Peptide-based immunization therapy for treatment of atherosclerosis |
| 04/09/2009 | US20090092611 Antibodies that bind both bcma and taci |
| 04/09/2009 | US20090092605 Compositions and methods for the treatment of immune related diseases |
| 04/09/2009 | US20090092546 Carrier molecules |
| 04/09/2009 | US20090092545 Antibodies that bind both bcma and taci |
| 04/09/2009 | DE102007046202A1 Medium for preventing or relieving pain, muscular strain particularly in muscle, for improvement of immune condition, wound healing or for reduction or recovery of arteriosclerosis, has mixture of tocotrienols and gamma linolenic acid |
| 04/09/2009 | CA2739523A1 Treatment of dissection, aneurysm, and atherosclerosis using granzyme b inhibitors |
| 04/09/2009 | CA2710406A1 Use of a peptide as a therapeutic agent |
| 04/09/2009 | CA2701618A1 Pharmaceutical composition for inhibiting amyloid-beta protein accumulation |
| 04/09/2009 | CA2701406A1 Benzoxazinone derivative |
| 04/09/2009 | CA2701397A1 Nerve cell death inhibitor |
| 04/09/2009 | CA2700691A1 New biaryl derivatives |
| 04/09/2009 | CA2700526A1 New compounds as adenosine a1 receptor antagonists |
| 04/09/2009 | CA2699597A1 Treatment of cardiovascular disorders using the cell differentiation signaling protein nell1 |
| 04/09/2009 | CA2699264A1 Substance p and thyrotropin releasing hormone for therapeutic applications |
| 04/09/2009 | CA2699260A1 Use of a peptide as a therapeutic agent |
| 04/09/2009 | CA2699255A1 Use of a peptide as a therapeutic agent |
| 04/09/2009 | CA2699114A1 Use of a peptide as a therapeutic agent |
| 04/09/2009 | CA2699113A1 Use of a peptide as a therapeutic agent |
| 04/09/2009 | CA2699109A1 Use of urocortin and corticotropin-releasing factor as therapeutic agents |
| 04/09/2009 | CA2699107A1 Use of a platelet fibrinogen receptor hexapeptide antagonist and alpha-endorphin as therapeutic agents |
| 04/09/2009 | CA2699105A1 Use of a peptide as a therapeutic agent |
| 04/09/2009 | CA2699104A1 Use of a peptide as a therapeutic agent |
| 04/09/2009 | CA2699078A1 Use of grf-1 (1-29 ) and corticotropin-releasing factor as therapeutic agents |
| 04/09/2009 | CA2699074A1 Use of a peptide as a therapeutic agent |
| 04/09/2009 | CA2699067A1 Use of rfrp, alone or in combination with neurokinin-b, as a therapeutic agent |
| 04/09/2009 | CA2698690A1 Thyrotropin releasing hormone for therapeutic applications |
| 04/09/2009 | CA2698688A1 Use of a peptide as a therapeutic agent |
| 04/09/2009 | CA2698687A1 Use of a peptide as a therapeutic agent |
| 04/09/2009 | CA2694322A1 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof |
| 04/09/2009 | CA2694313A1 Derivatives of 1-oxo-1,2-dihydroisoquinoline-5-carboxamides and of 4-oxo-3,4-dihydroquinazoline-8-carboxamides, preparation thereof and application thereof in therapeutics |
| 04/08/2009 | EP2045253A1 a-AMINO ACID DERIVATIVE AND PHARMACEUTICAL COMPRISING THE SAME AS ACTIVE INGREDIENT |
| 04/08/2009 | EP2045243A1 Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof |
| 04/08/2009 | EP2044958A2 Pharmaceutical composition for treating arteriosclerosis |
| 04/08/2009 | EP2044200A1 Uses and compositions comprising mirnas |
| 04/08/2009 | EP2044073A1 11beta-hydroxysteroid dehydrogenase type 1 active compounds |
| 04/08/2009 | EP2044059A1 2,5-disubstituted piperidines |
| 04/08/2009 | EP2044056A1 Pyrimidine derivatives as alk-5 inhibitors |
| 04/08/2009 | EP2044041A2 Isothiazolidines useful in the treatment of ocular hypertensive conditions |
| 04/08/2009 | EP2043671A2 Method and compositions for treating stroke with fever |
| 04/08/2009 | EP2043632A2 New indications for direct thrombin inhibitors |
| 04/08/2009 | EP2043631A2 New indications for direct thrombin inhibitors in the cardiovascular field |
| 04/08/2009 | EP1682122B9 Combinations of valsartan, amiloride or triamterine, and a diuretic |
| 04/08/2009 | EP1670470B1 Pyridine derivatives and use thereof as urotensin ii antagonists |
| 04/08/2009 | EP1545710B1 Use of n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide in the treatment of cancer |
| 04/08/2009 | EP1513811B1 Non-peptidic brs-3 agonists |
| 04/08/2009 | EP1462518B1 Adipocyte differentiation-associated gene and protein |
| 04/08/2009 | EP1448566B3 Chemokine receptor antagonists and methods of use thereof |
| 04/08/2009 | EP1415986B1 Spiro isobenzofuranes as neuropeptide y receptor antagonists |
| 04/08/2009 | EP1309355B9 Peptide and peptide mimetic conjugates with integrin-inhibitor properties |
| 04/08/2009 | EP1212299B1 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
| 04/08/2009 | CN101402923A Plant lactobacillus M1-UVs29 and uses thereof |
| 04/08/2009 | CN101402905A Fresh fruit white spirit and method of producing the same |
| 04/08/2009 | CN101402685A Neutralizing human anti-IGFR antibody |
| 04/08/2009 | CN101402675A Target restraint alpha Nu beta3 positive cell proliferation cyclic peptides |
| 04/08/2009 | CN101402641A Oxime derivatives containing thienopyridine, preparation method and application thereof |
| 04/08/2009 | CN101402565A Halogenated 2-(a-hydroxyl pentyl) benzoate, production method and uses thereof |
| 04/08/2009 | CN101401942A Azelnidipine composition |
| 04/08/2009 | CN101401930A Polypeptide and uses in preparing anti-heart failure and anti-inflammatory reaction medicament |
| 04/08/2009 | CN101401927A Chinese medicine powder for treating apoplexy |
| 04/08/2009 | CN101401917A Medicament formulation for dispelling wind and removing dampness to relieve itching |
| 04/08/2009 | CN101401910A Medicament for treating hypertension |
| 04/08/2009 | CN101401909A Pill for treating arterialocclusive angitis |
| 04/08/2009 | CN101401882A Medicine for external application for treating hemorrhoids |
| 04/08/2009 | CN101401875A Proprietary Chinese medicine for reducing blood pressure |
| 04/08/2009 | CN101401844A Red sage root extract and injection |
| 04/08/2009 | CN101401843A Extracting method for active principle of traditional Chinese medicine red sage root |
| 04/08/2009 | CN101401842A Chinese medicinal composition |
| 04/08/2009 | CN101401829A Wild Jinchai liveness extract, preparation and uses thereof |
| 04/08/2009 | CN101401802A Medicine for treating brain apoplexy |
| 04/08/2009 | CN101401800A Gamma-ethyl linolenate soft capsule and preparation thereof |
| 04/08/2009 | CN101401791A Timolol liposome and preparation method thereof |